COGT
Cogent Biosciences Inc
32.30$
+2.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 593.3% | -293.3% | -309.0% | -333.8% | -184.5% | -455.5% | – | – | – | – | – | |
| 6.0% | 13.1% | 14.0% | 13.6% | 5.7% | 9.1% | – | – | – | – | – | |
| 8.3% | 16.0% | 16.0% | 31.7% | 14.4% | 76.4% | – | – | – | – | – | |
| – | – | – | – | 13.8% | 553.3% | – | – | – | – | – | |
| 799.8% | -36.6% | -34.4% | -22.1% | -62.6% | -67.5% | – | – | – | – | – | |
| 66.8% | 52.0% | 10.9% | 5.6% | 0.1% | 4.1% | – | – | – | – | – | |
| -108.8% | -478.8% | 161.6% | -108.2% | 102.9% | 107.0% | – | – | – | – | – | |
| – | – | – | – | – | 1,581.3% | – | – | – | – | – | |
| 2,369.5% | -0.6% | -8.7% | 722.7% | 0.5% | 2,950.0% | – | – | – | – | – | |
| 2,854.0% | -772.8% | -156.1% | 280.7% | -81.1% | 2,601.5% | – | – | – | – | – | |
| 526.5% | -345.4% | -319.9% | -339.4% | -184.7% | -455.5% | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.